Elise Larson
Overview
Explore the profile of Elise Larson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
144
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fisher K, Kinsey R, Mohamath R, Phan T, Liang H, Orr M, et al.
NPJ Vaccines
. 2023 Feb;
8(1):14.
PMID: 36797262
Synthetic biology has allowed for the industrial production of supply-limited sesquiterpenoids such as the antimalarial drug artemisinin and β-farnesene. One of the only unmodified animal products used in medicine is...
2.
Gerhardt A, Voigt E, Archer M, Reed S, Larson E, Van Hoeven N, et al.
Mol Ther Methods Clin Dev
. 2022 Mar;
25:205-214.
PMID: 35308783
Current RNA vaccines against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) are limited by instability of both the RNA and the lipid nanoparticle delivery system, requiring storage at -20°C or -70°C...
3.
Abhyankar M, Orr M, Kinsey R, Sivananthan S, Nafziger A, Oakland D, et al.
Front Immunol
. 2021 Jul;
12:683157.
PMID: 34248966
Amebiasis is a neglected tropical disease caused by a. Although the disease burden varies geographically, amebiasis is estimated to account for some 55,000 deaths and millions of infections globally per...
4.
Gilchuk P, Bombardi R, Erasmus J, Tan Q, Nargi R, Soto C, et al.
Nat Biomed Eng
. 2020 Aug;
4(11):1030-1043.
PMID: 32747832
The emergence and re-emergence of highly virulent viral pathogens with the potential to cause a pandemic creates an urgent need for the accelerated discovery of antiviral therapeutics. Antiviral human monoclonal...
5.
Erasmus J, Khandhar A, Guderian J, Granger B, Archer J, Archer M, et al.
Mol Ther
. 2018 Aug;
26(10):2507-2522.
PMID: 30078765
Since the first demonstration of in vivo gene expression from an injected RNA molecule almost two decades ago, the field of RNA-based therapeutics is now taking significant strides, with many...